RESEARCH AND PRACTICE
Characterization of Dementia and Alzheimer’s Disease in an Older Population: Updated Incidence and Life Expectancy With and Without Dementia Sarah E. Tom, PhD, MPH, Rebecca A. Hubbard, PhD, Paul K. Crane, MD, MPH, Sebastien J. Haneuse, PhD, James Bowen, MD, Wayne C. McCormick, MD, MPH, Susan McCurry, PhD, and Eric B. Larson, MD, MPH
The number of people with dementia worldwide will rise with population aging, especially as the population of oldest adults increases. Understanding dementia risk and survival with dementia in older, community-dwelling adults is essential for health policymakers. Previous studies have produced somewhat conflicting estimates of trends in dementia and Alzheimer’s disease incidence for persons aged 85 years or older. Most studies found an increase in dementia incidence1---3 and Alzheimer’s disease incidence1,3,4 with each successive age group. However, some studies found a decrease in dementia incidence5,6 and Alzheimer’s disease incidence5 in the oldest people in the population. Others found a decrease in dementia incidence for women only4,7 or a decrease in dementia incidence8 and Alzheimer’s disease incidence7 for men only. Few studies have estimated the effect of dementia on survival of the total population, which consists of those with dementia, those who will develop dementia, and those who will not develop dementia. Life expectancy with dementia quantifies the effect of dementia on the survival of the total population. This metric is defined as the average number of years one is expected to live with dementia.9 This measure incorporates both risk of dementia incidence and expectation of life based on population-level trends rather than the trends of only those with dementia. A related measure is percentage of total life expectancy without dementia, which relates the proportion of life expectancy in a healthy state. The few studies that used these types of metrics found that older age was associated with shorter life expectancy with dementia compared with younger age and that women had a longer life expectancy with dementia than did men.9---12 These studies also found that percentage of total life expectancy without dementia
Objectives. We estimated dementia incidence rates, life expectancies with and without dementia, and percentage of total life expectancy without dementia. Methods. We studied 3605 members of Group Health (Seattle, WA) aged 65 years or older who did not have dementia at enrollment to the Adult Changes in Thought study between 1994 and 2008. We estimated incidence rates of Alzheimer’s disease and dementia, as well as life expectancies with and without dementia, defined as the average number of years one is expected to live with and without dementia, and percentage of total life expectancy without dementia. Results. Dementia incidence increased through ages 85 to 89 years (74.2 cases per 1000 person-years) and 90 years or older (105 cases per 1000 person-years). Life expectancy without dementia and percentage of total life expectancy without dementia decreased with age. Life expectancy with dementia was longer in women and people with at least a college degree. Percentage of total life expectancy without dementia was greater in younger age groups, men, and those with more education. Conclusions. Efforts to delay onset of dementia, if successful, would likely benefit older adults of all ages. (Am J Public Health. 2015;105:408–413. doi:10. 2105/AJPH.2014.301935)
decreased with increasing age and was higher among men than among women at each age.9---12 Studies of dementia incidence1,8 and Alzheimer’s disease incidence1 are often limited by small sample sizes in the oldest ages and therefore combine ages 85 years and older into a single group. Studies that included more detailed age groups past 85 years had small sample sizes in these oldest age groups, which might have limited the precision and stability of incidence estimates for both dementia2,3,7 and Alzheimer’s disease.3,7 A few studies estimated life expectancy with and without dementia but primarily used cross-sectional data with prevalence estimates of dementia.10,12,13 This study design is not ideal for understanding dementia incidence and mortality in the general population, which is the information that is the most useful for informing health policy. In addition, no study, to our knowledge, has yet examined the association between educational attainment and life expectancy with and without dementia. We used data from a long-running, population-based cohort study to estimate
408 | Research and Practice | Peer Reviewed | Tom et al.
incidence of dementia and Alzheimer’s disease, and to calculate life expectancy with and without dementia and percentage of life expectancy without dementia. We tested the following hypotheses: d
d
d
d
Incidence of dementia and Alzheimer’s disease increases with age. Life expectancy with dementia decreases with age. Women have a longer life expectancy with dementia than do men but a smaller percentage of total life expectancy without dementia than do men. Higher levels of education are related to longer life expectancy without dementia and greater percentage of total life expectancy without dementia.
METHODS Details on the Adult Changes in Thought (ACT) study, a prospective cohort study of dementia, have been published previously.3
American Journal of Public Health | February 2015, Vol 105, No. 2
RESEARCH AND PRACTICE
Participants are members of Group Health, an integrated health care delivery system in the Northwest United States. The original cohort consisted of 2581 people enrolled in 1994 to 1996. An expansion cohort (n = 811) was enrolled in 2000 to 2002. In 2004, the study began ongoing enrollment to replace people who die, develop dementia, or drop out. The analysis included 3605 participants who were enrolled in ACT and who had follow-up data available on September 30, 2010. ACT participants are recruited from a random sample of community-dwelling members aged 65 years or older who are invited to an intake visit. Consenting individuals found to be free of dementia are enrolled. ACT participants are evaluated for dementia at baseline and every 2 years with the Cognitive Abilities Screening Instrument.14 Those with Cognitive Abilities Screening Instrument scores lower than 86 are referred for a complete diagnostic evaluation that includes physical and neurological examinations, neuropsychological testing, and laboratory and imaging studies if not already available. A consensus conference including the study physicians, a neuropsychologist, and a research nurse determines diagnoses of dementia based on Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV), criteria15 and of Alzheimer’s disease based on DSM-IV and National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer’s Disease and Related Disorders Association criteria.16 Participants remain in the cohort until they are determined to have dementia or Alzheimer’s disease or are censored as a result of death or discontinuation of participation in the study. Only dementia diagnoses from ACT evaluations were used in analysis. Mortality was confirmed through death certificates, state death registry data, annual telephone contact with family members of study participants with dementia, quarterly mailings to participants, and thorough review of local obituaries. We described the distribution of participant characteristics, including age, gender, race/ ethnicity, education, health conditions detected during follow-up, and baseline body mass index (BMI; defined as weight in kilograms divided by the square of height in meters), stratified by observed dementia incidence. We calculated age-specific incidence of dementia and
Alzheimer’s disease with the person-years approach17 by dividing the number of cases by the person-years at risk in 5-year age intervals starting from age 65 years. We multiplied these rates by 1000 to report rates per 1000 personyears. The number of person-years contributed by a participant without dementia was the time between baseline examination to last follow-up examination. The number of person-years contributed by a participant with dementia was the time from baseline to the midpoint between the visit at which dementia was diagnosed and the previous follow-up examination. For participants who died or dropped out of the study, the date of last follow-up examination was used as the end point. We calculated confidence intervals (CIs) for incidence rates with a Poisson distribution for the number of cases within each age interval. We used a 3-state, piecewise homogeneous Markov model to estimate life expectancy with and without dementia.18,19 Life expectancy without dementia at a given age was defined as the average number of years a participant who attained that age without dementia was expected to live free of dementia.9 Life expectancy with dementia was the average number of years a participant who attained that age without dementia was expected to live following a subsequent dementia diagnosis. Thus, these measures incorporate both the risk of developing dementia and the average number of years lived following a dementia diagnosis. By contrast, other measures of survival include only those who currently have dementia.20 We also calculated percentage of total life expectancy without dementia. In our Markov model, we specified states of no dementia, dementia, and death. We assumed a progressive model structure, allowing transitions between no dementia and dementia or death and between dementia and death. The piecewise, homogeneous Markov model assumes constant instantaneous transition rates within each age stratum. Age strata used in our model were 70, 71, 72, 73, 74, 75 to 76, 77 to 79, 80 to 84, 85 to 89, and 90 years or older. On the basis of estimated age stratum---specific transition rates, we then estimated life expectancy and dementia-free life expectancy in a simulated cohort of 1 000 000 individuals. For each individual, we simulated a life history beginning at age 70 years based on maximum likelihood
February 2015, Vol 105, No. 2 | American Journal of Public Health
estimates from the Markov model. We then computed mean age at dementia diagnosis, mean age at death, and mean number of years between dementia diagnosis and death across the cohort. To construct 95% CIs, we repeated the cohort simulation with the 2.5th and 97.5th percentiles of the estimated transition rates. To investigate the association between gender, education, and life expectancy, we estimated the Markov model allowing for gender-specific and education-specific transition intensities. For gender, we assumed a proportional hazards structure. Thus, transition intensities in all age strata were assumed to be multiplied by the same factor associated with gender. The proportional hazards structure for education resulted in model instability, so we allowed for separate education effects in each age stratum. Life expectancies for individuals of varying educational attainment were reported at age 75 years because these estimates were more stable than those for older or younger individuals because of the sample size. Trends with respect to educational attainment were similar for older and younger individuals. All statistical analyses were performed with R 2.15.0 (R Foundation for Statistical Computing, Vienna, Austria).
RESULTS From 1994 to 2010, 4455 participants enrolled in the ACT study. Among the enrollees, 3605 participants had at least 1 follow-up examination. A consensus diagnosis of dementia was determined in 815 participants, with 639 diagnoses of possible or probable Alzheimer’s disease and 176 diagnoses of dementia attributable to other causes. The median length of follow-up was 6.3 years (interquartile range = 4.0---10.5 years, with a maximum of 16.4 years), accounting for 24 052 person-years. Of the participants with Alzheimer’s disease, 68.9% died during follow-up, compared with 81.3% of those with dementia attributable to other causes and 43.7% of those with no dementia diagnosis. Participants who received a diagnosis of dementia during follow-up were more likely to be older, to be female, and to have achieved at most a high school education (Table 1). Obesity and proportion with detection of hypertension, stroke, and myocardial
Tom et al. | Peer Reviewed | Research and Practice | 409
RESEARCH AND PRACTICE
TABLE 1—Characteristics of Adult Changes in Thought Study Cohort Sample (n = 3605), by Dementia Diagnosis During Follow-Up: Adult Changes in Thought Study, Northwestern United States, 1994–2010 Diagnosed With Dementia (n = 815), No. (%)
No Dementia During Follow-Up (n = 2790), No. (%)
65–69 70–74
89 (10.9) 201 (24.7)
762 (27.3) 898 (32.2)
75–79
227 (27.9)
576 (20.6)
80–84
188 (23.1)
366 (13.1)
‡ 85
110 (13.5)
188 (6.7)
Male
307 (37.7)
1141 (40.9)
Female
508 (62.3)
1649 (59.1)
Baseline age, y
Gender
Education £ high school
359 (44.0)
901 (32.3)
Some college
221 (27.1)
732 (26.2)
‡ college
235 (28.8)
1156 (41.4)
White
749 (91.9)
2525 (90.7)
Black
31 (3.8)
118 (4.2)
Asian
22 (2.7)
99 (3.5)
3 (0.4) 0 (0.0)
5 (0.2) 1 (0.0)
10 (1.2)
37 (1.3)
Race/ethnicity
American Indian/Alaska Native Hawaiian/Pacific Islander Other Baseline body mass index, kg/m2 < 18.5
13 (1.6)
23 (0.8)
18.5–24.9
275 (34.4)
862 (31.6)
25.0–29.9
332 (41.5)
1127 (41.3)
‡ 30.0
180 (22.5)
720 (26.4)
656 (80.5)
2212 (79.3)
Detection of health conditions during follow-up Hypertension Stroke Myocardial infarction Nursing home entry during follow-up
68 (8.3)
167 (6.0)
119 (14.6)
383 (13.7)
15 (1.8)
16 (0.6)
Note. Percentages were calculated based on all individuals with nonmissing data for each variable. Number of observations with missing data were education (1), race/ethnicity (5), body mass index (73), stroke (7), and myocardial infarction (7). The sample size was n = 3605.
infarction during follow-up were similar regardless of dementia diagnosis. At the end of follow-up, 72.9% of those aged 65 to 69 years at baseline were still alive, whereas 14.7% of those aged 90 years or older at baseline were still alive. At the end of follow-up, 10.5% of those aged 65 to 69 years at baseline had a dementia diagnosis, whereas 5.6% of the respondents in this age group had an Alzheimer’s disease diagnosis. Of those aged 90 years or older at baseline, at the end of follow-up, 42.6% had a dementia diagnosis,
and 33.8% had an Alzheimer’s disease diagnosis. The incidence rate of dementia increased with each successive age group (Table 2), reflecting higher incidence rates of both Alzheimer’s disease and non---Alzheimer’s disease dementia. These patterns were apparent in men and women. The incidence rates for dementia were similar for men and women through ages 80 to 84 years. In the 2 older age groups, dementia incidence rates were higher in women than in men, with a larger gender
410 | Research and Practice | Peer Reviewed | Tom et al.
difference for Alzheimer’s disease than for non---Alzheimer’s disease dementia. Life expectancy without dementia (average number of years a participant who attained that age is expected to live without dementia) decreased over ages 70 to 90 years (Table 3). At age 90 years, life expectancy without dementia was 4.2 years (95% CI = 3.5, 5.1). Life expectancy with dementia (average number of years a participant who attained that age is expected to live with dementia) also decreased over age but at a more gradual rate. At age 90 years, life expectancy with dementia was 1.3 years (95% CI = 1.2, 1.5). The percentage of total life expectancy without dementia also decreased with age. At all ages, life expectancy without dementia was about 1 year longer for women than for men, and life expectancy with dementia was about 0.5 years longer for women than for men. However, at all ages, percentage of total life expectancy without dementia was slightly higher for men than for women. Life expectancy without dementia was approximately 0.5 years longer for study participants who completed college or more education than for those with lower educational attainment among respondents aged 75 years (Table 4). Conversely, life expectancy with dementia was approximately 0.5 years shorter for participants who completed college or more education compared with those with lower educational attainment among respondents aged 75 years. Percentage of life expectancy free of dementia increased with greater educational attainment, and this gain was slightly larger for women than for men.
DISCUSSION In a cohort free of dementia and cognitive impairment at baseline, dementia incidence increased after age 85 years in men and women. Although this result is not surprising, our study is notable for providing detailed information on the oldest Americans. Our findings are unique because of the use of longitudinal data and in estimating trends among the entire population, not just in patients who currently have dementia. Of the study participants aged 70 years or older, oldest adults, men, and those with greater educational attainment had shorter life expectancies with
American Journal of Public Health | February 2015, Vol 105, No. 2
RESEARCH AND PRACTICE
TABLE 2—Age-Specific Incidence Rates per 1000 Person-Years for Dementia, Alzheimer’s Disease, and Non–Alzheimer’s Disease Dementia: Adult Changes in Thought Study, Northwestern United States, 1994–2010 All Dementia Cases Age Group, Years
No. of Person-Years
No. of Cases
Rate (95% CI)
Alzheimer’s Disease Cases No. of Cases
Non–Alzheimer’s Disease Dementia Cases
Rate (95% CI)
No. of Cases
Rate (95% CI)
2.7 (1.0, 7.2)
All participants 65–69
1471
8
5.4 (2.7, 10.9)
4
2.7 (1.0, 7.2)
4
70–74
5525
52
9.4 (7.2, 12.4)
30
5.4 (3.8, 7.8)
22
4.0 (2.6, 6.0)
75–79 80–84
6996 5858
135 272
19.3 (16.3, 22.8) 46.4 (41.2, 52.3)
101 211
14.4 (11.9, 17.5) 36.0 (31.5, 41.2)
34 61
4.9 (3.5, 6.8) 10.4 (8.1, 13.4)
85–89
3021
224
74.2 (65.1, 84.5)
188
62.2 (54.0, 71.8)
36
11.9 (8.6, 16.5)
‡ 90
1181
124
105.0 (88.0, 125.2)
105
88.9 (73.4, 107.6)
19
16.1 (10.3, 25.2)
Male participants 65–69
677
5
7.4 (3.1, 17.7)
3
4.4 (1.4, 13.7)
2
3.0 (0.7, 11.8)
70–74
2367
27
11.4 (7.8, 16.6)
13
5.5 (3.2, 9.5)
14
5.9 (3.5, 10.0)
75–79
2849
60
21.1 (16.4, 27.1)
42
14.7 (10.9, 20.0)
18
6.3 (4.0, 10.0)
80–84 85–89
2275 1091
112 69
49.2 (40.9, 59.2) 63.2 (49.9, 80.1)
79 58
34.7 (27.8, 43.3) 53.2 (41.1, 68.8)
33 11
14.5 (10.3, 20.4) 10.1 (5.6, 18.2)
‡ 90
346
34
98.3 (70.2, 137.5)
29
83.8 (58.2, 120.6)
5
14.4 (6.0, 34.7)
Female participants 65–69
795
3
3.8 (1.2, 11.7)
1
1.3 (0.2, 8.9)
2
2.5 (0.6, 10.1)
70–74
3158
25
7.9 (5.3, 11.7)
17
5.4 (3.3, 8.7)
8
2.5 (1.3, 5.1)
75–79
4147
75
18.1 (14.4, 22.7)
59
14.2 (11.0, 18.4)
16
3.9 (2.4, 6.3)
80–84
3583
160
44.7 (38.2, 52.1)
132
36.8 (31.1, 43.7)
28
7.8 (5.4, 11.3)
85–89 ‡ 90
1929 835
155 90
80.3 (68.6, 94.0) 107.8 (87.7, 132.5)
130 76
67.4 (56.7, 80.0) 91.0 (72.7, 113.9)
25 14
13.0 (8.8, 19.2) 16.8 (9.9, 28.3)
Note. CI = confidence interval. The sample size was n = 3605.
dementia (average years with dementia) than did their counterparts. Younger adults, women, and those with greater educational attainment had longer life expectancies without dementia (average years without dementia) than did their counterparts. Younger adults, men, and those with greater educational attainment also had higher percentages of total life expectancies without dementia than did their counterparts. Our findings supported our hypotheses: dementia incidence increases with age; life expectancy with dementia decreases with age; women have longer life expectancy than men regardless of dementia and a lower percentage of total life expectancy without dementia; and higher education levels are associated with longer life expectancy with and without dementia and greater percentage of total life expectancy without dementia. Our finding of an increase in dementia incidence with each successive age group was consistent with most previous findings for the overall population3
and for men4,5 and women2---5,7 only. Similarly, our finding of an increase in Alzheimer’s disease incidence with each successive age group for the overall population3 and for men2,3,5,7 and women3---5,7 only was consistent with most previous findings. Our findings regarding life expectancy with and without dementia and percentage of total life expectancy without dementia in men and women by age were consistent with previous results.9---13 We found that greater education was related to increased life expectancy without dementia and a greater percentage of life expectancy without dementia. To our knowledge, no previous studies have estimated dementia-free life expectancy according to educational attainment. Consistent with our findings, previous studies found that people with lower educational attainment have a slightly longer life expectancy with cognitive impairment.21,22 More highly educated people may have greater cognitive reserve that delays reaching the threshold at which cognitive impairment is
February 2015, Vol 105, No. 2 | American Journal of Public Health
detectable and may have access to more resources that benefit health.21 This study had several limitations. Because the respondents in the sample were from a particular region of the United States and were relatively racially homogeneous, the results may not be representative of national trends. In addition, our piecewise homogeneous Markov model assumed that transition rates to dementia and death were constant within certain age intervals. This assumption was necessary to obtain estimates in age ranges for which few deaths or dementia cases were observed. Although we used the smallest practical age intervals, our results may be somewhat dependent on this choice of intervals. The continued increase in dementia incidence into the 10th decade of life has major population health implications for an aging population with increased obesity prevalence at all stages of life. Between 2010 and 2050, the proportion of US adults aged 65 years or older is expected to increase from 13% to
Tom et al. | Peer Reviewed | Research and Practice | 411
RESEARCH AND PRACTICE
TABLE 3—Total Life Expectancy, Life Expectancies With and Without Dementia, and Percentage of Total Life Expectancy Without Dementia in Years at Ages 70–90 Years, by Age and Gender: Adult Changes in Thought Study, Northwestern United States, 1994–2010
Age, Years
Total Life Expectancy, Rate (95% CI)
Life Expectancy Without Dementia, Rate (95% CI)
Life Expectancy with Dementia, Rate (95% CI)
% of Total Life Expectancy Without Dementia, Age (95% CI)
Overall 70
17.1 (0.0, 19.1)
15.1 (0.0, 16.9)
2.0 (0.0, 2.2)
88.4 (83.0, 92.3)
75
13.4 (12.2, 14.9)
11.4 (10.4, 12.7)
2.0 (1.8, 2.1)
85.5 (79.2, 90.2)
80
10.1 (8.9, 11.3)
8.2 (7.3, 9.2)
1.9 (1.7, 2.2)
79.5 (74.5, 83.7)
85
7.2 (6.4, 12.3)
5.6 (4.9, 6.5)
1.6 (1.5, 1.8)
76.8 (71.3, 81.5)
90
5.5 (4.7, 6.6)
4.2 (3.5, 5.1)
1.3 (1.2, 1.5)
77.4 (70.0, 83.3)
70 75
16.0 (0.0, 18.0) 12.3 (10.8, 13.9)
14.3 (0.0, 16.1) 10.7 (9.5, 12.1)
1.7 (0.0, 1.9) 1.6 (1.4, 1.8)
89.5 (87.6, 91.1) 87.3 (81.8, 91.3)
80
9.0 (8.1, 10.4)
7.5 (6.7, 8.6)
1.5 (1.4, 1.8)
82.0 (75.4, 87.1)
85
6.3 (5.4, 7.4)
5.0 (4.2, 5.9)
1.3 (1.1, 1.5)
79.3 (73.8, 83.9)
90
4.5 (3.6, 5.5)
3.5 (2.8, 4.3)
1.0 (0.8, 1.2)
80.1 (74.4, 84.9)
Male participants
Female participants 70
18.0 (0.0, 20.1)
15.7 (0.0, 17.6)
2.3 (0.0, 2.5)
87.3 (54.3, 97.5)
75
14.3 (12.7, 15.9)
12.1 (10.8, 13.4)
2.2 (2.0, 2.5)
84.2 (79.6, 87.8)
80 85
10.8 (9.6, 12.2) 7.8 (6.8, 9.1)
8.6 (7.7, 9.8) 6.0 (5.2, 7.0)
2.1 (1.9, 2.4) 1.9 (1.6, 2.1)
78.6 (73.3, 83.1) 75.1 (69.5, 79.9)
90
6.0 (5.0, 7.5)
4.5 (3.7, 5.7)
1.5 (1.3, 1.8)
75.0 (69.0, 80.2)
Note. The sample size was n = 3605.
20%, and the percentage aged 85 years or older is expected to double from 2% to 4%.23 In addition to an increase in the number of
people at greater dementia risk because of demographic shifts, the obesity epidemic means that older adults as a group will be at
greater risk for so-called mixed dementia, which is typically the coexistence of Alzheimer’s disease and vascular dementia.24,25 In 2009 to 2010, nearly 40% of adults aged 60 years or older were obese (BMI ‡ 30 kg/m2); nearly 20% of adolescents aged 12 to 19 years were obese.26 Thus, current age cohorts are experiencing a high lifetime exposure to obesity-related vascular risks, which will add to the vascular risks of dementia that are specific to older age. Although beyond the scope of this current study, investigation of BMI in relation to life expectancy with and without dementia would inform outcomes related to the obesity epidemic. Life expectancy with dementia is a population health measure that accounts for risk of dementia incidence as well as survival following dementia onset. We used life expectancy with and without dementia to describe ACT participants, who were dementia-free at study enrollment. For the average ACT participant, the expectation is that life with dementia will be a few years and a small proportion of overall life expectancy. The apparent low life expectancy with dementia reflects, in part, a relatively modest dementia incidence rate until late in life. At older ages, the percentage of total life expectancy without dementia decreases. Thus, the burden of suffering reflected in this population measure affects a progressively greater proportion of remaining life in persons 80, 85,
TABLE 4—Total Life Expectancy, Life Expectancies With and Without Dementia, and Percentage of Total Life Expectancy Free of Dementia at Age 75 Years, by Education and Gender: Adult Changes in Thought Study, Northwestern United States, 1994–2010 Educational Attainment
Total Life Expectancy, Rate (95% CI)
Life Expectancy Without Dementia, Rate (95% CI)
Life Expectancy With Dementia, Rate (95% CI)
% Total Life Expectancy Without Dementia, Age (95% CI)
Overall £ high school
13.3 (10.9, 15.6)
11.1 (9.2, 13.1)
2.1 (1.7, 2.5)
84.1 (77.6, 89.0)
Some college
13.9 (11.0, 16.7)
11.7 (9.3, 14.1)
2.2 (1.6, 2.6)
84.9 (78.2, 89.9)
‡ college
13.4 (2.3, 16.0)
11.8 (0.0, 14.0)
1.6 (1.4, 1.7)
88.3 (84.3, 91.4)
Male £ high school
11.9 (9.4, 14.5)
10.2 (8.1, 12.3)
1.7 (1.4, 2.1)
86.2 (80.8, 90.2)
Some college
12.8 (9.9, 16.0)
11.3 (8.8, 14.0)
1.5 (1.1, 2.0)
88.9 (84.2, 92.3)
‡ college
12.3 (7.9, 15.0)
10.9 (6.5, 13.0)
1.4 (1.4, 1.9)
88.7 (85.8, 91.0)
Female £ high school
14.1 (11.7, 16.8)
11.7 (9.7, 13.9)
2.4 (1.9, 2.8)
82.8 (77.7, 87.0)
Some college
14.4 (11.5, 17.4)
12.0 (9.7, 14.5)
2.4 (1.9, 2.9)
83.3 (78.9, 87.0)
‡ college
14.5 (9.8, 17.8)
12.8 (8.2, 15.5)
1.7 (1.6, 2.3)
87.7 (84.6, 90.3)
Note. CI = confidence interval. The sample size was n = 3605.
412 | Research and Practice | Peer Reviewed | Tom et al.
American Journal of Public Health | February 2015, Vol 105, No. 2
RESEARCH AND PRACTICE
and 90 years old. The low percentage of overall life expectancy lived with dementia also reflects gains in life expectancy free of dementia. In industrialized countries, overall life expectancy has increased since the second half of the 20th century, in large part because of decreases in mortality in older adulthood.27 At the same time, a compression of cognitive impairment may have occurred such that the onset of dementia has been delayed and people are spending fewer years of life with dementia. Several studies reported slower cognitive decline and lower prevalence rates in age cohorts born later in the 20th century.28,29 Therefore, on the population level, dementia represents a relatively small proportion of expected life. Nonetheless, we realize that the consequences of dementia to the people affected and their families are tremendous and a great fear in an aging society. In the ACT cohort, considering only participants with an Alzheimer’s disease diagnosis, the average survival for women was 5.7 years and for men was 4.2 years.20 Yearly US costs of dementia are estimated at $42 000 to $56 000 per person.30 This study provides reliable, up-to-date information about the effect of dementia on specific population groups. We hope our results will contribute to public health policies that delay dementia onset and improve the quality of life for patients with dementia and their caregivers. j
About the Authors Sarah E. Tom is with the Pharmaceutical Health Services Research Department, School of Pharmacy, University of Maryland, Baltimore. Rebecca A. Hubbard and Eric B. Larson are with the Group Health Research Institute, Group Health Cooperative, Seattle, WA. Paul K. Crane and Eric B. Larson are with the Department of Medicine, University of Washington, Seattle. Sebastien J. Haneuse is with the Department of Biostatistics, School of Public Health, Harvard University, Cambridge, MA. James Bowen is with the Swedish Neuroscience Institute, Seattle, WA. Wayne C. McCormick is with the Harborview Medical Center, Seattle, WA. Susan McCurry is with Psychosocial and Community Health, School of Nursing, University of Washington. Correspondence should be sent to Sarah E. Tom, PhD, MPH, 220 Arch St, 12th Floor, Room 01-224, Baltimore, MD 21201 (e-mail: [email protected]). Reprints can be ordered at http://www.ajph.org by clicking the “Reprints” link. This article was accepted February 14, 2014.
Contributors S. E. Tom, R. A. Hubbard, S. J. Haneuse, and E. B. Larson designed the study. J. Bowen, W. C. McCormick, S. McCurry, and E. B. Larson oversaw the data collection. R. A. Hubbard performed the statistical analysis. All
authors contributed to data interpretation and the writing of the article.
14. Teng EL, Hasegawa K, Homma A, et al. The Cognitive Abilities Screening Instrument (CASI): a practical test for cross-cultural epidemiological studies of dementia. Int Psychogeriatr. 1994;6(1):45---58, discussion 62.
Acknowledgments This study received grant support from the National Institutes of Health (grants AG 06781, AG 027677, and HD 052023).
Human Participant Protection This study was approved by the institutional review boards of Group Health and the University of Washington, Seattle. All Adult Changes in Thought (ACT) participants provide written informed consent for baseline and follow-up assessments at the time of enrollment into ACT.
References 1. Kawas C, Gray S, Brookmeyer R, Fozard J, Zonderman A. Age-specific incidence rates of Alzheimer’s disease: The Baltimore Longitudinal Study of Aging. Neurology. 2000;54(11):2072---2077. 2. Ott A, Breteler MM, van Harskamp F, Stijnen T, Hofman A. Incidence and risk of dementia: The Rotterdam Study. Am J Epidemiol. 1998;147(6):574---580. 3. Kukull WA, Higdon R, Bowen JD, et al. Dementia and Alzheimer disease incidence: a prospective cohort study. Arch Neurol. 2002;59(11):1737---1746. 4. Fratiglioni L, Viitanen M, von Strauss E, Tontodonati V, Herlitz A, Winblad B. Very old women at highest risk of dementia and Alzheimer’s disease: incidence data from the Kungsholmen Project, Stockholm. Neurology. 1997;48(1):132---138. 5. Miech RA, Breitner JC, Zandi PP, Khachaturian AS, Anthony JC, Mayer L. Incidence of AD may decline in the early 90s for men, later for women: the Cache County study. Neurology. 2002;58(2):209---218. 6. Rocca WA, Cha RH, Waring SC, Kokmen E. Incidence of dementia and Alzheimer’s disease: a reanalysis of data from Rochester, Minnesota, 1975-1984. Am J Epidemiol. 1998;148(1):51---62. 7. Andersen K, Launer LJ, Dewey ME, et al. Gender differences in the incidence of AD and vascular dementia: the EURODEM Studies. EURODEM Incidence Research Group. Neurology. 1999;53(9):1992---1997. 8. Fitzpatrick AL, Kuller LH, Ives DG, et al. Incidence and prevalence of dementia in the Cardiovascular Health Study. J Am Geriatr Soc. 2004;52(2):195---204. 9. Sauvaget C, Tsuji I, Minami Y, et al. Dementia-free life expectancy among elderly Japanese. Gerontology. 1997;43(3):168---175. 10. Perenboom RJ, Boshuizen HC, Breteler MM, Ott A, Van de Water HP. Dementia-free life expectancy (DemFLE) in the Netherlands. Soc Sci Med. 1996;43 (12):1703---1707. 11. Sauvaget C, Tsuji I, Haan MN, Hisamichi S. Trends in dementia-free life expectancy among elderly members of a large health maintenance organization. Int J Epidemiol. 1999;28(6):1110---1118.
15. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC; American Psychiatric Association; 1994. 16. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology. 1984;34(7):939---944. 17. Breslow NE, Day NE. Statistical methods in cancer research, volume II---the design and analysis of cohort studies. IARC Sci Publ. 1987;(82):1---406. 18. Land KC, Guralnik JM, Blazer DG. Estimating increment-decrement life tables with multiple covariates from panel data: the case of active life expectancy. Demography. 1994;31(2):297---319. 19. Gentleman RC, Lawless JF, Lindsey JC, Yan P. Multistate Markov models for analysing incomplete disease history data with illustrations for HIV disease. Stat Med. 1994;13(8):805---821. 20. Larson EB, Shadlen MF, Wang L, et al. Survival after initial diagnosis of Alzheimer disease. Ann Intern Med. 2004;140(7):501---509. 21. Lièvre A, Alley D, Crimmins EM. Educational differentials in life expectancy with cognitive impairment among the elderly in the United States. J Aging Health. 2008;20(4):456---477. 22. Matthews FE, Jagger C, Miller LL, Brayne C, MRC CFAS. Education differences in life expectancy with cognitive impairment. J Gerontol A Biol Sci Med Sci. 2009;64A(1):125---131. 23. Projections of the population by selected age groups and sex for the United States: 2010 to 2050 (NP2008T2). 2008. Available at: http://www.census.gov/population/ projections/data/national/2008/summarytables.html. Accessed November 15, 2012. 24. Langa KM, Foster NL, Larson EB. Mixed dementia: emerging concepts and therapeutic implications. JAMA. 2004;292(23):2901---2908. 25. Larson EB, Yaffe K, Langa KM. New insights into the dementia epidemic. N Engl J Med. 2013;369(24):2275--2277. 26. Ogden C, Carroll MD, Kit BK, eds. Prevalence of Obesity in the United States, 2009 --- 2010. Hyattsville, MD: National Center for Health Statistics; 2012. NCHS data brief 82. 27. Wilmoth JR. Demography of longevity: past, present, and future trends. Exp Gerontol. 2000;35(9-10):1111-- 1129. 28. Christensen K, Thinggaard M, Oksuzyan A, et al. Physical and cognitive functioning of people older than 90 years: a comparison of two Danish cohorts born 10 years apart. Lancet. 2013;382(9903):1507---1513.
12. Ritchie K, Robine JM, Letenneur L, Dartigues JF. Dementia-free life expectancy in France. Am J Public Health. 1994;84(2):232---236.
29. Matthews FE, Arthur A, Barnes LE, et al. A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II. Lancet. 2013;382 (9902):1405---1412.
13. Dubois MF, Hebert R. Cognitive-impairment-free life expectancy for Canadian seniors. Dement Geriatr Cogn Disord. 2006;22(4):327---333.
30. Hurd MD, Martorell P, Delavande A, Mullen KJ, Langa KM. Monetary costs of dementia in the United States. N Engl J Med. 2013;368(14):1326---1334.
February 2015, Vol 105, No. 2 | American Journal of Public Health
Tom et al. | Peer Reviewed | Research and Practice | 413
Characterization of Dementia and Alzheimer’s Disease in an Older Population: Updated Incidence and Life Expectancy With and Without Dementia Sarah E. Tom, PhD, MPH, Rebecca A. Hubbard, PhD, Paul K. Crane, MD, MPH, Sebastien J. Haneuse, PhD, James Bowen, MD, Wayne C. McCormick, MD, MPH, Susan McCurry, PhD, and Eric B. Larson, MD, MPH
The number of people with dementia worldwide will rise with population aging, especially as the population of oldest adults increases. Understanding dementia risk and survival with dementia in older, community-dwelling adults is essential for health policymakers. Previous studies have produced somewhat conflicting estimates of trends in dementia and Alzheimer’s disease incidence for persons aged 85 years or older. Most studies found an increase in dementia incidence1---3 and Alzheimer’s disease incidence1,3,4 with each successive age group. However, some studies found a decrease in dementia incidence5,6 and Alzheimer’s disease incidence5 in the oldest people in the population. Others found a decrease in dementia incidence for women only4,7 or a decrease in dementia incidence8 and Alzheimer’s disease incidence7 for men only. Few studies have estimated the effect of dementia on survival of the total population, which consists of those with dementia, those who will develop dementia, and those who will not develop dementia. Life expectancy with dementia quantifies the effect of dementia on the survival of the total population. This metric is defined as the average number of years one is expected to live with dementia.9 This measure incorporates both risk of dementia incidence and expectation of life based on population-level trends rather than the trends of only those with dementia. A related measure is percentage of total life expectancy without dementia, which relates the proportion of life expectancy in a healthy state. The few studies that used these types of metrics found that older age was associated with shorter life expectancy with dementia compared with younger age and that women had a longer life expectancy with dementia than did men.9---12 These studies also found that percentage of total life expectancy without dementia
Objectives. We estimated dementia incidence rates, life expectancies with and without dementia, and percentage of total life expectancy without dementia. Methods. We studied 3605 members of Group Health (Seattle, WA) aged 65 years or older who did not have dementia at enrollment to the Adult Changes in Thought study between 1994 and 2008. We estimated incidence rates of Alzheimer’s disease and dementia, as well as life expectancies with and without dementia, defined as the average number of years one is expected to live with and without dementia, and percentage of total life expectancy without dementia. Results. Dementia incidence increased through ages 85 to 89 years (74.2 cases per 1000 person-years) and 90 years or older (105 cases per 1000 person-years). Life expectancy without dementia and percentage of total life expectancy without dementia decreased with age. Life expectancy with dementia was longer in women and people with at least a college degree. Percentage of total life expectancy without dementia was greater in younger age groups, men, and those with more education. Conclusions. Efforts to delay onset of dementia, if successful, would likely benefit older adults of all ages. (Am J Public Health. 2015;105:408–413. doi:10. 2105/AJPH.2014.301935)
decreased with increasing age and was higher among men than among women at each age.9---12 Studies of dementia incidence1,8 and Alzheimer’s disease incidence1 are often limited by small sample sizes in the oldest ages and therefore combine ages 85 years and older into a single group. Studies that included more detailed age groups past 85 years had small sample sizes in these oldest age groups, which might have limited the precision and stability of incidence estimates for both dementia2,3,7 and Alzheimer’s disease.3,7 A few studies estimated life expectancy with and without dementia but primarily used cross-sectional data with prevalence estimates of dementia.10,12,13 This study design is not ideal for understanding dementia incidence and mortality in the general population, which is the information that is the most useful for informing health policy. In addition, no study, to our knowledge, has yet examined the association between educational attainment and life expectancy with and without dementia. We used data from a long-running, population-based cohort study to estimate
408 | Research and Practice | Peer Reviewed | Tom et al.
incidence of dementia and Alzheimer’s disease, and to calculate life expectancy with and without dementia and percentage of life expectancy without dementia. We tested the following hypotheses: d
d
d
d
Incidence of dementia and Alzheimer’s disease increases with age. Life expectancy with dementia decreases with age. Women have a longer life expectancy with dementia than do men but a smaller percentage of total life expectancy without dementia than do men. Higher levels of education are related to longer life expectancy without dementia and greater percentage of total life expectancy without dementia.
METHODS Details on the Adult Changes in Thought (ACT) study, a prospective cohort study of dementia, have been published previously.3
American Journal of Public Health | February 2015, Vol 105, No. 2
RESEARCH AND PRACTICE
Participants are members of Group Health, an integrated health care delivery system in the Northwest United States. The original cohort consisted of 2581 people enrolled in 1994 to 1996. An expansion cohort (n = 811) was enrolled in 2000 to 2002. In 2004, the study began ongoing enrollment to replace people who die, develop dementia, or drop out. The analysis included 3605 participants who were enrolled in ACT and who had follow-up data available on September 30, 2010. ACT participants are recruited from a random sample of community-dwelling members aged 65 years or older who are invited to an intake visit. Consenting individuals found to be free of dementia are enrolled. ACT participants are evaluated for dementia at baseline and every 2 years with the Cognitive Abilities Screening Instrument.14 Those with Cognitive Abilities Screening Instrument scores lower than 86 are referred for a complete diagnostic evaluation that includes physical and neurological examinations, neuropsychological testing, and laboratory and imaging studies if not already available. A consensus conference including the study physicians, a neuropsychologist, and a research nurse determines diagnoses of dementia based on Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV), criteria15 and of Alzheimer’s disease based on DSM-IV and National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer’s Disease and Related Disorders Association criteria.16 Participants remain in the cohort until they are determined to have dementia or Alzheimer’s disease or are censored as a result of death or discontinuation of participation in the study. Only dementia diagnoses from ACT evaluations were used in analysis. Mortality was confirmed through death certificates, state death registry data, annual telephone contact with family members of study participants with dementia, quarterly mailings to participants, and thorough review of local obituaries. We described the distribution of participant characteristics, including age, gender, race/ ethnicity, education, health conditions detected during follow-up, and baseline body mass index (BMI; defined as weight in kilograms divided by the square of height in meters), stratified by observed dementia incidence. We calculated age-specific incidence of dementia and
Alzheimer’s disease with the person-years approach17 by dividing the number of cases by the person-years at risk in 5-year age intervals starting from age 65 years. We multiplied these rates by 1000 to report rates per 1000 personyears. The number of person-years contributed by a participant without dementia was the time between baseline examination to last follow-up examination. The number of person-years contributed by a participant with dementia was the time from baseline to the midpoint between the visit at which dementia was diagnosed and the previous follow-up examination. For participants who died or dropped out of the study, the date of last follow-up examination was used as the end point. We calculated confidence intervals (CIs) for incidence rates with a Poisson distribution for the number of cases within each age interval. We used a 3-state, piecewise homogeneous Markov model to estimate life expectancy with and without dementia.18,19 Life expectancy without dementia at a given age was defined as the average number of years a participant who attained that age without dementia was expected to live free of dementia.9 Life expectancy with dementia was the average number of years a participant who attained that age without dementia was expected to live following a subsequent dementia diagnosis. Thus, these measures incorporate both the risk of developing dementia and the average number of years lived following a dementia diagnosis. By contrast, other measures of survival include only those who currently have dementia.20 We also calculated percentage of total life expectancy without dementia. In our Markov model, we specified states of no dementia, dementia, and death. We assumed a progressive model structure, allowing transitions between no dementia and dementia or death and between dementia and death. The piecewise, homogeneous Markov model assumes constant instantaneous transition rates within each age stratum. Age strata used in our model were 70, 71, 72, 73, 74, 75 to 76, 77 to 79, 80 to 84, 85 to 89, and 90 years or older. On the basis of estimated age stratum---specific transition rates, we then estimated life expectancy and dementia-free life expectancy in a simulated cohort of 1 000 000 individuals. For each individual, we simulated a life history beginning at age 70 years based on maximum likelihood
February 2015, Vol 105, No. 2 | American Journal of Public Health
estimates from the Markov model. We then computed mean age at dementia diagnosis, mean age at death, and mean number of years between dementia diagnosis and death across the cohort. To construct 95% CIs, we repeated the cohort simulation with the 2.5th and 97.5th percentiles of the estimated transition rates. To investigate the association between gender, education, and life expectancy, we estimated the Markov model allowing for gender-specific and education-specific transition intensities. For gender, we assumed a proportional hazards structure. Thus, transition intensities in all age strata were assumed to be multiplied by the same factor associated with gender. The proportional hazards structure for education resulted in model instability, so we allowed for separate education effects in each age stratum. Life expectancies for individuals of varying educational attainment were reported at age 75 years because these estimates were more stable than those for older or younger individuals because of the sample size. Trends with respect to educational attainment were similar for older and younger individuals. All statistical analyses were performed with R 2.15.0 (R Foundation for Statistical Computing, Vienna, Austria).
RESULTS From 1994 to 2010, 4455 participants enrolled in the ACT study. Among the enrollees, 3605 participants had at least 1 follow-up examination. A consensus diagnosis of dementia was determined in 815 participants, with 639 diagnoses of possible or probable Alzheimer’s disease and 176 diagnoses of dementia attributable to other causes. The median length of follow-up was 6.3 years (interquartile range = 4.0---10.5 years, with a maximum of 16.4 years), accounting for 24 052 person-years. Of the participants with Alzheimer’s disease, 68.9% died during follow-up, compared with 81.3% of those with dementia attributable to other causes and 43.7% of those with no dementia diagnosis. Participants who received a diagnosis of dementia during follow-up were more likely to be older, to be female, and to have achieved at most a high school education (Table 1). Obesity and proportion with detection of hypertension, stroke, and myocardial
Tom et al. | Peer Reviewed | Research and Practice | 409
RESEARCH AND PRACTICE
TABLE 1—Characteristics of Adult Changes in Thought Study Cohort Sample (n = 3605), by Dementia Diagnosis During Follow-Up: Adult Changes in Thought Study, Northwestern United States, 1994–2010 Diagnosed With Dementia (n = 815), No. (%)
No Dementia During Follow-Up (n = 2790), No. (%)
65–69 70–74
89 (10.9) 201 (24.7)
762 (27.3) 898 (32.2)
75–79
227 (27.9)
576 (20.6)
80–84
188 (23.1)
366 (13.1)
‡ 85
110 (13.5)
188 (6.7)
Male
307 (37.7)
1141 (40.9)
Female
508 (62.3)
1649 (59.1)
Baseline age, y
Gender
Education £ high school
359 (44.0)
901 (32.3)
Some college
221 (27.1)
732 (26.2)
‡ college
235 (28.8)
1156 (41.4)
White
749 (91.9)
2525 (90.7)
Black
31 (3.8)
118 (4.2)
Asian
22 (2.7)
99 (3.5)
3 (0.4) 0 (0.0)
5 (0.2) 1 (0.0)
10 (1.2)
37 (1.3)
Race/ethnicity
American Indian/Alaska Native Hawaiian/Pacific Islander Other Baseline body mass index, kg/m2 < 18.5
13 (1.6)
23 (0.8)
18.5–24.9
275 (34.4)
862 (31.6)
25.0–29.9
332 (41.5)
1127 (41.3)
‡ 30.0
180 (22.5)
720 (26.4)
656 (80.5)
2212 (79.3)
Detection of health conditions during follow-up Hypertension Stroke Myocardial infarction Nursing home entry during follow-up
68 (8.3)
167 (6.0)
119 (14.6)
383 (13.7)
15 (1.8)
16 (0.6)
Note. Percentages were calculated based on all individuals with nonmissing data for each variable. Number of observations with missing data were education (1), race/ethnicity (5), body mass index (73), stroke (7), and myocardial infarction (7). The sample size was n = 3605.
infarction during follow-up were similar regardless of dementia diagnosis. At the end of follow-up, 72.9% of those aged 65 to 69 years at baseline were still alive, whereas 14.7% of those aged 90 years or older at baseline were still alive. At the end of follow-up, 10.5% of those aged 65 to 69 years at baseline had a dementia diagnosis, whereas 5.6% of the respondents in this age group had an Alzheimer’s disease diagnosis. Of those aged 90 years or older at baseline, at the end of follow-up, 42.6% had a dementia diagnosis,
and 33.8% had an Alzheimer’s disease diagnosis. The incidence rate of dementia increased with each successive age group (Table 2), reflecting higher incidence rates of both Alzheimer’s disease and non---Alzheimer’s disease dementia. These patterns were apparent in men and women. The incidence rates for dementia were similar for men and women through ages 80 to 84 years. In the 2 older age groups, dementia incidence rates were higher in women than in men, with a larger gender
410 | Research and Practice | Peer Reviewed | Tom et al.
difference for Alzheimer’s disease than for non---Alzheimer’s disease dementia. Life expectancy without dementia (average number of years a participant who attained that age is expected to live without dementia) decreased over ages 70 to 90 years (Table 3). At age 90 years, life expectancy without dementia was 4.2 years (95% CI = 3.5, 5.1). Life expectancy with dementia (average number of years a participant who attained that age is expected to live with dementia) also decreased over age but at a more gradual rate. At age 90 years, life expectancy with dementia was 1.3 years (95% CI = 1.2, 1.5). The percentage of total life expectancy without dementia also decreased with age. At all ages, life expectancy without dementia was about 1 year longer for women than for men, and life expectancy with dementia was about 0.5 years longer for women than for men. However, at all ages, percentage of total life expectancy without dementia was slightly higher for men than for women. Life expectancy without dementia was approximately 0.5 years longer for study participants who completed college or more education than for those with lower educational attainment among respondents aged 75 years (Table 4). Conversely, life expectancy with dementia was approximately 0.5 years shorter for participants who completed college or more education compared with those with lower educational attainment among respondents aged 75 years. Percentage of life expectancy free of dementia increased with greater educational attainment, and this gain was slightly larger for women than for men.
DISCUSSION In a cohort free of dementia and cognitive impairment at baseline, dementia incidence increased after age 85 years in men and women. Although this result is not surprising, our study is notable for providing detailed information on the oldest Americans. Our findings are unique because of the use of longitudinal data and in estimating trends among the entire population, not just in patients who currently have dementia. Of the study participants aged 70 years or older, oldest adults, men, and those with greater educational attainment had shorter life expectancies with
American Journal of Public Health | February 2015, Vol 105, No. 2
RESEARCH AND PRACTICE
TABLE 2—Age-Specific Incidence Rates per 1000 Person-Years for Dementia, Alzheimer’s Disease, and Non–Alzheimer’s Disease Dementia: Adult Changes in Thought Study, Northwestern United States, 1994–2010 All Dementia Cases Age Group, Years
No. of Person-Years
No. of Cases
Rate (95% CI)
Alzheimer’s Disease Cases No. of Cases
Non–Alzheimer’s Disease Dementia Cases
Rate (95% CI)
No. of Cases
Rate (95% CI)
2.7 (1.0, 7.2)
All participants 65–69
1471
8
5.4 (2.7, 10.9)
4
2.7 (1.0, 7.2)
4
70–74
5525
52
9.4 (7.2, 12.4)
30
5.4 (3.8, 7.8)
22
4.0 (2.6, 6.0)
75–79 80–84
6996 5858
135 272
19.3 (16.3, 22.8) 46.4 (41.2, 52.3)
101 211
14.4 (11.9, 17.5) 36.0 (31.5, 41.2)
34 61
4.9 (3.5, 6.8) 10.4 (8.1, 13.4)
85–89
3021
224
74.2 (65.1, 84.5)
188
62.2 (54.0, 71.8)
36
11.9 (8.6, 16.5)
‡ 90
1181
124
105.0 (88.0, 125.2)
105
88.9 (73.4, 107.6)
19
16.1 (10.3, 25.2)
Male participants 65–69
677
5
7.4 (3.1, 17.7)
3
4.4 (1.4, 13.7)
2
3.0 (0.7, 11.8)
70–74
2367
27
11.4 (7.8, 16.6)
13
5.5 (3.2, 9.5)
14
5.9 (3.5, 10.0)
75–79
2849
60
21.1 (16.4, 27.1)
42
14.7 (10.9, 20.0)
18
6.3 (4.0, 10.0)
80–84 85–89
2275 1091
112 69
49.2 (40.9, 59.2) 63.2 (49.9, 80.1)
79 58
34.7 (27.8, 43.3) 53.2 (41.1, 68.8)
33 11
14.5 (10.3, 20.4) 10.1 (5.6, 18.2)
‡ 90
346
34
98.3 (70.2, 137.5)
29
83.8 (58.2, 120.6)
5
14.4 (6.0, 34.7)
Female participants 65–69
795
3
3.8 (1.2, 11.7)
1
1.3 (0.2, 8.9)
2
2.5 (0.6, 10.1)
70–74
3158
25
7.9 (5.3, 11.7)
17
5.4 (3.3, 8.7)
8
2.5 (1.3, 5.1)
75–79
4147
75
18.1 (14.4, 22.7)
59
14.2 (11.0, 18.4)
16
3.9 (2.4, 6.3)
80–84
3583
160
44.7 (38.2, 52.1)
132
36.8 (31.1, 43.7)
28
7.8 (5.4, 11.3)
85–89 ‡ 90
1929 835
155 90
80.3 (68.6, 94.0) 107.8 (87.7, 132.5)
130 76
67.4 (56.7, 80.0) 91.0 (72.7, 113.9)
25 14
13.0 (8.8, 19.2) 16.8 (9.9, 28.3)
Note. CI = confidence interval. The sample size was n = 3605.
dementia (average years with dementia) than did their counterparts. Younger adults, women, and those with greater educational attainment had longer life expectancies without dementia (average years without dementia) than did their counterparts. Younger adults, men, and those with greater educational attainment also had higher percentages of total life expectancies without dementia than did their counterparts. Our findings supported our hypotheses: dementia incidence increases with age; life expectancy with dementia decreases with age; women have longer life expectancy than men regardless of dementia and a lower percentage of total life expectancy without dementia; and higher education levels are associated with longer life expectancy with and without dementia and greater percentage of total life expectancy without dementia. Our finding of an increase in dementia incidence with each successive age group was consistent with most previous findings for the overall population3
and for men4,5 and women2---5,7 only. Similarly, our finding of an increase in Alzheimer’s disease incidence with each successive age group for the overall population3 and for men2,3,5,7 and women3---5,7 only was consistent with most previous findings. Our findings regarding life expectancy with and without dementia and percentage of total life expectancy without dementia in men and women by age were consistent with previous results.9---13 We found that greater education was related to increased life expectancy without dementia and a greater percentage of life expectancy without dementia. To our knowledge, no previous studies have estimated dementia-free life expectancy according to educational attainment. Consistent with our findings, previous studies found that people with lower educational attainment have a slightly longer life expectancy with cognitive impairment.21,22 More highly educated people may have greater cognitive reserve that delays reaching the threshold at which cognitive impairment is
February 2015, Vol 105, No. 2 | American Journal of Public Health
detectable and may have access to more resources that benefit health.21 This study had several limitations. Because the respondents in the sample were from a particular region of the United States and were relatively racially homogeneous, the results may not be representative of national trends. In addition, our piecewise homogeneous Markov model assumed that transition rates to dementia and death were constant within certain age intervals. This assumption was necessary to obtain estimates in age ranges for which few deaths or dementia cases were observed. Although we used the smallest practical age intervals, our results may be somewhat dependent on this choice of intervals. The continued increase in dementia incidence into the 10th decade of life has major population health implications for an aging population with increased obesity prevalence at all stages of life. Between 2010 and 2050, the proportion of US adults aged 65 years or older is expected to increase from 13% to
Tom et al. | Peer Reviewed | Research and Practice | 411
RESEARCH AND PRACTICE
TABLE 3—Total Life Expectancy, Life Expectancies With and Without Dementia, and Percentage of Total Life Expectancy Without Dementia in Years at Ages 70–90 Years, by Age and Gender: Adult Changes in Thought Study, Northwestern United States, 1994–2010
Age, Years
Total Life Expectancy, Rate (95% CI)
Life Expectancy Without Dementia, Rate (95% CI)
Life Expectancy with Dementia, Rate (95% CI)
% of Total Life Expectancy Without Dementia, Age (95% CI)
Overall 70
17.1 (0.0, 19.1)
15.1 (0.0, 16.9)
2.0 (0.0, 2.2)
88.4 (83.0, 92.3)
75
13.4 (12.2, 14.9)
11.4 (10.4, 12.7)
2.0 (1.8, 2.1)
85.5 (79.2, 90.2)
80
10.1 (8.9, 11.3)
8.2 (7.3, 9.2)
1.9 (1.7, 2.2)
79.5 (74.5, 83.7)
85
7.2 (6.4, 12.3)
5.6 (4.9, 6.5)
1.6 (1.5, 1.8)
76.8 (71.3, 81.5)
90
5.5 (4.7, 6.6)
4.2 (3.5, 5.1)
1.3 (1.2, 1.5)
77.4 (70.0, 83.3)
70 75
16.0 (0.0, 18.0) 12.3 (10.8, 13.9)
14.3 (0.0, 16.1) 10.7 (9.5, 12.1)
1.7 (0.0, 1.9) 1.6 (1.4, 1.8)
89.5 (87.6, 91.1) 87.3 (81.8, 91.3)
80
9.0 (8.1, 10.4)
7.5 (6.7, 8.6)
1.5 (1.4, 1.8)
82.0 (75.4, 87.1)
85
6.3 (5.4, 7.4)
5.0 (4.2, 5.9)
1.3 (1.1, 1.5)
79.3 (73.8, 83.9)
90
4.5 (3.6, 5.5)
3.5 (2.8, 4.3)
1.0 (0.8, 1.2)
80.1 (74.4, 84.9)
Male participants
Female participants 70
18.0 (0.0, 20.1)
15.7 (0.0, 17.6)
2.3 (0.0, 2.5)
87.3 (54.3, 97.5)
75
14.3 (12.7, 15.9)
12.1 (10.8, 13.4)
2.2 (2.0, 2.5)
84.2 (79.6, 87.8)
80 85
10.8 (9.6, 12.2) 7.8 (6.8, 9.1)
8.6 (7.7, 9.8) 6.0 (5.2, 7.0)
2.1 (1.9, 2.4) 1.9 (1.6, 2.1)
78.6 (73.3, 83.1) 75.1 (69.5, 79.9)
90
6.0 (5.0, 7.5)
4.5 (3.7, 5.7)
1.5 (1.3, 1.8)
75.0 (69.0, 80.2)
Note. The sample size was n = 3605.
20%, and the percentage aged 85 years or older is expected to double from 2% to 4%.23 In addition to an increase in the number of
people at greater dementia risk because of demographic shifts, the obesity epidemic means that older adults as a group will be at
greater risk for so-called mixed dementia, which is typically the coexistence of Alzheimer’s disease and vascular dementia.24,25 In 2009 to 2010, nearly 40% of adults aged 60 years or older were obese (BMI ‡ 30 kg/m2); nearly 20% of adolescents aged 12 to 19 years were obese.26 Thus, current age cohorts are experiencing a high lifetime exposure to obesity-related vascular risks, which will add to the vascular risks of dementia that are specific to older age. Although beyond the scope of this current study, investigation of BMI in relation to life expectancy with and without dementia would inform outcomes related to the obesity epidemic. Life expectancy with dementia is a population health measure that accounts for risk of dementia incidence as well as survival following dementia onset. We used life expectancy with and without dementia to describe ACT participants, who were dementia-free at study enrollment. For the average ACT participant, the expectation is that life with dementia will be a few years and a small proportion of overall life expectancy. The apparent low life expectancy with dementia reflects, in part, a relatively modest dementia incidence rate until late in life. At older ages, the percentage of total life expectancy without dementia decreases. Thus, the burden of suffering reflected in this population measure affects a progressively greater proportion of remaining life in persons 80, 85,
TABLE 4—Total Life Expectancy, Life Expectancies With and Without Dementia, and Percentage of Total Life Expectancy Free of Dementia at Age 75 Years, by Education and Gender: Adult Changes in Thought Study, Northwestern United States, 1994–2010 Educational Attainment
Total Life Expectancy, Rate (95% CI)
Life Expectancy Without Dementia, Rate (95% CI)
Life Expectancy With Dementia, Rate (95% CI)
% Total Life Expectancy Without Dementia, Age (95% CI)
Overall £ high school
13.3 (10.9, 15.6)
11.1 (9.2, 13.1)
2.1 (1.7, 2.5)
84.1 (77.6, 89.0)
Some college
13.9 (11.0, 16.7)
11.7 (9.3, 14.1)
2.2 (1.6, 2.6)
84.9 (78.2, 89.9)
‡ college
13.4 (2.3, 16.0)
11.8 (0.0, 14.0)
1.6 (1.4, 1.7)
88.3 (84.3, 91.4)
Male £ high school
11.9 (9.4, 14.5)
10.2 (8.1, 12.3)
1.7 (1.4, 2.1)
86.2 (80.8, 90.2)
Some college
12.8 (9.9, 16.0)
11.3 (8.8, 14.0)
1.5 (1.1, 2.0)
88.9 (84.2, 92.3)
‡ college
12.3 (7.9, 15.0)
10.9 (6.5, 13.0)
1.4 (1.4, 1.9)
88.7 (85.8, 91.0)
Female £ high school
14.1 (11.7, 16.8)
11.7 (9.7, 13.9)
2.4 (1.9, 2.8)
82.8 (77.7, 87.0)
Some college
14.4 (11.5, 17.4)
12.0 (9.7, 14.5)
2.4 (1.9, 2.9)
83.3 (78.9, 87.0)
‡ college
14.5 (9.8, 17.8)
12.8 (8.2, 15.5)
1.7 (1.6, 2.3)
87.7 (84.6, 90.3)
Note. CI = confidence interval. The sample size was n = 3605.
412 | Research and Practice | Peer Reviewed | Tom et al.
American Journal of Public Health | February 2015, Vol 105, No. 2
RESEARCH AND PRACTICE
and 90 years old. The low percentage of overall life expectancy lived with dementia also reflects gains in life expectancy free of dementia. In industrialized countries, overall life expectancy has increased since the second half of the 20th century, in large part because of decreases in mortality in older adulthood.27 At the same time, a compression of cognitive impairment may have occurred such that the onset of dementia has been delayed and people are spending fewer years of life with dementia. Several studies reported slower cognitive decline and lower prevalence rates in age cohorts born later in the 20th century.28,29 Therefore, on the population level, dementia represents a relatively small proportion of expected life. Nonetheless, we realize that the consequences of dementia to the people affected and their families are tremendous and a great fear in an aging society. In the ACT cohort, considering only participants with an Alzheimer’s disease diagnosis, the average survival for women was 5.7 years and for men was 4.2 years.20 Yearly US costs of dementia are estimated at $42 000 to $56 000 per person.30 This study provides reliable, up-to-date information about the effect of dementia on specific population groups. We hope our results will contribute to public health policies that delay dementia onset and improve the quality of life for patients with dementia and their caregivers. j
About the Authors Sarah E. Tom is with the Pharmaceutical Health Services Research Department, School of Pharmacy, University of Maryland, Baltimore. Rebecca A. Hubbard and Eric B. Larson are with the Group Health Research Institute, Group Health Cooperative, Seattle, WA. Paul K. Crane and Eric B. Larson are with the Department of Medicine, University of Washington, Seattle. Sebastien J. Haneuse is with the Department of Biostatistics, School of Public Health, Harvard University, Cambridge, MA. James Bowen is with the Swedish Neuroscience Institute, Seattle, WA. Wayne C. McCormick is with the Harborview Medical Center, Seattle, WA. Susan McCurry is with Psychosocial and Community Health, School of Nursing, University of Washington. Correspondence should be sent to Sarah E. Tom, PhD, MPH, 220 Arch St, 12th Floor, Room 01-224, Baltimore, MD 21201 (e-mail: [email protected]). Reprints can be ordered at http://www.ajph.org by clicking the “Reprints” link. This article was accepted February 14, 2014.
Contributors S. E. Tom, R. A. Hubbard, S. J. Haneuse, and E. B. Larson designed the study. J. Bowen, W. C. McCormick, S. McCurry, and E. B. Larson oversaw the data collection. R. A. Hubbard performed the statistical analysis. All
authors contributed to data interpretation and the writing of the article.
14. Teng EL, Hasegawa K, Homma A, et al. The Cognitive Abilities Screening Instrument (CASI): a practical test for cross-cultural epidemiological studies of dementia. Int Psychogeriatr. 1994;6(1):45---58, discussion 62.
Acknowledgments This study received grant support from the National Institutes of Health (grants AG 06781, AG 027677, and HD 052023).
Human Participant Protection This study was approved by the institutional review boards of Group Health and the University of Washington, Seattle. All Adult Changes in Thought (ACT) participants provide written informed consent for baseline and follow-up assessments at the time of enrollment into ACT.
References 1. Kawas C, Gray S, Brookmeyer R, Fozard J, Zonderman A. Age-specific incidence rates of Alzheimer’s disease: The Baltimore Longitudinal Study of Aging. Neurology. 2000;54(11):2072---2077. 2. Ott A, Breteler MM, van Harskamp F, Stijnen T, Hofman A. Incidence and risk of dementia: The Rotterdam Study. Am J Epidemiol. 1998;147(6):574---580. 3. Kukull WA, Higdon R, Bowen JD, et al. Dementia and Alzheimer disease incidence: a prospective cohort study. Arch Neurol. 2002;59(11):1737---1746. 4. Fratiglioni L, Viitanen M, von Strauss E, Tontodonati V, Herlitz A, Winblad B. Very old women at highest risk of dementia and Alzheimer’s disease: incidence data from the Kungsholmen Project, Stockholm. Neurology. 1997;48(1):132---138. 5. Miech RA, Breitner JC, Zandi PP, Khachaturian AS, Anthony JC, Mayer L. Incidence of AD may decline in the early 90s for men, later for women: the Cache County study. Neurology. 2002;58(2):209---218. 6. Rocca WA, Cha RH, Waring SC, Kokmen E. Incidence of dementia and Alzheimer’s disease: a reanalysis of data from Rochester, Minnesota, 1975-1984. Am J Epidemiol. 1998;148(1):51---62. 7. Andersen K, Launer LJ, Dewey ME, et al. Gender differences in the incidence of AD and vascular dementia: the EURODEM Studies. EURODEM Incidence Research Group. Neurology. 1999;53(9):1992---1997. 8. Fitzpatrick AL, Kuller LH, Ives DG, et al. Incidence and prevalence of dementia in the Cardiovascular Health Study. J Am Geriatr Soc. 2004;52(2):195---204. 9. Sauvaget C, Tsuji I, Minami Y, et al. Dementia-free life expectancy among elderly Japanese. Gerontology. 1997;43(3):168---175. 10. Perenboom RJ, Boshuizen HC, Breteler MM, Ott A, Van de Water HP. Dementia-free life expectancy (DemFLE) in the Netherlands. Soc Sci Med. 1996;43 (12):1703---1707. 11. Sauvaget C, Tsuji I, Haan MN, Hisamichi S. Trends in dementia-free life expectancy among elderly members of a large health maintenance organization. Int J Epidemiol. 1999;28(6):1110---1118.
15. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC; American Psychiatric Association; 1994. 16. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology. 1984;34(7):939---944. 17. Breslow NE, Day NE. Statistical methods in cancer research, volume II---the design and analysis of cohort studies. IARC Sci Publ. 1987;(82):1---406. 18. Land KC, Guralnik JM, Blazer DG. Estimating increment-decrement life tables with multiple covariates from panel data: the case of active life expectancy. Demography. 1994;31(2):297---319. 19. Gentleman RC, Lawless JF, Lindsey JC, Yan P. Multistate Markov models for analysing incomplete disease history data with illustrations for HIV disease. Stat Med. 1994;13(8):805---821. 20. Larson EB, Shadlen MF, Wang L, et al. Survival after initial diagnosis of Alzheimer disease. Ann Intern Med. 2004;140(7):501---509. 21. Lièvre A, Alley D, Crimmins EM. Educational differentials in life expectancy with cognitive impairment among the elderly in the United States. J Aging Health. 2008;20(4):456---477. 22. Matthews FE, Jagger C, Miller LL, Brayne C, MRC CFAS. Education differences in life expectancy with cognitive impairment. J Gerontol A Biol Sci Med Sci. 2009;64A(1):125---131. 23. Projections of the population by selected age groups and sex for the United States: 2010 to 2050 (NP2008T2). 2008. Available at: http://www.census.gov/population/ projections/data/national/2008/summarytables.html. Accessed November 15, 2012. 24. Langa KM, Foster NL, Larson EB. Mixed dementia: emerging concepts and therapeutic implications. JAMA. 2004;292(23):2901---2908. 25. Larson EB, Yaffe K, Langa KM. New insights into the dementia epidemic. N Engl J Med. 2013;369(24):2275--2277. 26. Ogden C, Carroll MD, Kit BK, eds. Prevalence of Obesity in the United States, 2009 --- 2010. Hyattsville, MD: National Center for Health Statistics; 2012. NCHS data brief 82. 27. Wilmoth JR. Demography of longevity: past, present, and future trends. Exp Gerontol. 2000;35(9-10):1111-- 1129. 28. Christensen K, Thinggaard M, Oksuzyan A, et al. Physical and cognitive functioning of people older than 90 years: a comparison of two Danish cohorts born 10 years apart. Lancet. 2013;382(9903):1507---1513.
12. Ritchie K, Robine JM, Letenneur L, Dartigues JF. Dementia-free life expectancy in France. Am J Public Health. 1994;84(2):232---236.
29. Matthews FE, Arthur A, Barnes LE, et al. A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II. Lancet. 2013;382 (9902):1405---1412.
13. Dubois MF, Hebert R. Cognitive-impairment-free life expectancy for Canadian seniors. Dement Geriatr Cogn Disord. 2006;22(4):327---333.
30. Hurd MD, Martorell P, Delavande A, Mullen KJ, Langa KM. Monetary costs of dementia in the United States. N Engl J Med. 2013;368(14):1326---1334.
February 2015, Vol 105, No. 2 | American Journal of Public Health
Tom et al. | Peer Reviewed | Research and Practice | 413
